AnPac Announces the Plan of US$5,000,000 Private Placement
05. Dezember 2022 07:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food Market
05. Dezember 2022 07:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
AnPac Announces Regaining Compliance with Nasdaq Listing Requirement
30. November 2022 07:00 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
AnPac Bio Announces Changes to the Board of Directors
10. November 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Nov. 10, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
AnPac Bio Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting $1 Bid Price Compliance Rule On or Before Nov. 23, 2022
04. November 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Nov. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Announces Plan to Implement ADS Ratio Change
18. Oktober 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Oct. 18, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
AnPac Bio Announces Board and Management Changes
03. Oktober 2022 17:45 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and...
AnPac Bio and New Investor Group Sign Equity Investment Totaling $3.67 Million
26. September 2022 22:51 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Appeals NASDAQ Delisting Notice; Hearing Granted and Scheduled for October 20, 2022
19. September 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Sept. 19, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Appeal
12. September 2022 00:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...